These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32117000)

  • 41. Quality of life and excessive daytime sleepiness in children and adolescents with myotonic dystrophy type 1.
    Ho G; Widger J; Cardamone M; Farrar MA
    Sleep Med; 2017 Apr; 32():92-96. PubMed ID: 28366348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficient and highly sensitive screen for myotonic dystrophy type 1 using a one-step triplet-primed PCR and melting curve assay.
    Lian M; Rajan-Babu IS; Singh K; Lee CG; Law HY; Chong SS
    J Mol Diagn; 2015 Mar; 17(2):128-35. PubMed ID: 25684273
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1).
    Heatwole C; Bode R; Johnson N; Quinn C; Martens W; McDermott MP; Rothrock N; Thornton C; Vickrey B; Victorson D; Moxley R
    Neurology; 2012 Jul; 79(4):348-57. PubMed ID: 22786587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stapedial reflex in myotonic dystrophy type 1 and CTG repeat expansion.
    Osanai R; Kinoshita M; Hirose K
    J Neurol; 2001 Dec; 248(12):1056-61. PubMed ID: 12013582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myotonic dystrophytype 1 - report of non-24-h sleep-wake disorder with excessive daytime sleepiness.
    Filho LHP; Gomes ACD; Gonçalves B; Tufik S; Coelho FM
    Chronobiol Int; 2018 Sep; 35(9):1326-1328. PubMed ID: 29764215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions.
    Ho G; Cardamone M; Farrar M
    World J Clin Pediatr; 2015 Nov; 4(4):66-80. PubMed ID: 26566479
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myotonic dystrophies.
    Huang CC; Kuo HC
    Chang Gung Med J; 2005 Aug; 28(8):517-26. PubMed ID: 16265841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral Appliance Therapy in Patients With Daytime Sleepiness and Snoring or Mild to Moderate Sleep Apnea: A Randomized Clinical Trial.
    Marklund M; Carlberg B; Forsgren L; Olsson T; Stenlund H; Franklin KA
    JAMA Intern Med; 2015 Aug; 175(8):1278-85. PubMed ID: 26030264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and genetic characteristics of childhood-onset myotonic dystrophy.
    Stokes M; Varughese N; Iannaccone S; Castro D
    Muscle Nerve; 2019 Dec; 60(6):732-738. PubMed ID: 31520483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels.
    Nakamura M; Kanbayashi T; Sugiura T; Inoue Y
    J Sleep Res; 2011 Mar; 20(1 Pt 1):45-9. PubMed ID: 20642748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and neuroradiological correlates of sleep in myotonic dystrophy type 1.
    Hamilton MJ; Atalaia A; McLean J; Cumming SA; Evans JJ; Ballantyne B; Jampana R; The Scottish Myotonic Dystrophy Consortium ; Longman C; Livingston E; van der Plas E; Koscik T; Nopoulos P; Farrugia ME; Monckton DG
    Neuromuscul Disord; 2022 May; 32(5):377-389. PubMed ID: 35361525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sleepiness and Sleep-related Breathing Disorders in Myotonic Dystrophy and Responses to Treatment: A Prospective Cohort Study.
    West SD; Lochmüller H; Hughes J; Atalaia A; Marini-Bettolo C; Baudouin SV; Anderson KN
    J Neuromuscul Dis; 2016 Nov; 3(4):529-537. PubMed ID: 27911338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and tolerability of a 20-mg dose of methylphenidate for the treatment of daytime sleepiness in adult patients with myotonic dystrophy type 1: a 2-center, randomized, double-blind, placebo-controlled, 3-week crossover trial.
    Puymirat J; Bouchard JP; Mathieu J
    Clin Ther; 2012 May; 34(5):1103-11. PubMed ID: 22578232
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
    Talbot K; Stradling J; Crosby J; Hilton-Jones D
    Neuromuscul Disord; 2003 Jun; 13(5):357-64. PubMed ID: 12798791
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of common sleep disorders.
    Ramar K; Olson EJ
    Am Fam Physician; 2013 Aug; 88(4):231-8. PubMed ID: 23944726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Central sleep apnea and daytime sleepiness in Niemann-Pick type C disease: a report of 2 cases.
    Zhang Y; Cheng Y; Li N; Hou Y; Jiao L; Yuan Y; Wang L; Huang Z; Han F; Li H; Zhan S
    J Clin Sleep Med; 2023 Feb; 19(2):409-414. PubMed ID: 36199263
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Obstructive sleep apnea/hypopnea syndrome.
    De Backer W
    Panminerva Med; 2013 Jun; 55(2):191-5. PubMed ID: 23676959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sleep-disordered breathing and effects of non-invasive ventilation on objective sleep and nocturnal respiration in patients with myotonic dystrophy type I.
    Spiesshoefer J; Runte M; Heidbreder A; Dreher M; Young P; Brix T; Boentert M
    Neuromuscul Disord; 2019 Apr; 29(4):302-309. PubMed ID: 30898523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Responsiveness of Daytime Sleepiness and Fatigue Scales in Myotonic Dystrophy Type 1.
    Laberge L; Gallais B; Auclair J; Dauvilliers Y; Côté I; Mathieu J; Gagnon C
    Can J Neurol Sci; 2022 Mar; 49(2):287-290. PubMed ID: 33875033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia.
    Compta Y; Santamaria J; Ratti L; Tolosa E; Iranzo A; Muñoz E; Valldeoriola F; Casamitjana R; Ríos J; Marti MJ
    Brain; 2009 Dec; 132(Pt 12):3308-17. PubMed ID: 19858078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.